Assessment With CCTA and MRI in Asymptomatic Patients With Type 2 Diabetes for Detection of Unrecognized Myocardial Scar in Subclinical Coronary Atherosclerosis
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 351 participants.
Also called NCT01254552
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Phase 4
- Enrolled
- 351 participants
- Sponsor
- Registry
-
NCT01254552
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT01254552. Allocation not applicable; no masking; primary purpose diagnostic. Start 2010-08 (actual); primary completion 2011-09 (actual). Results posted on 2019-05-31.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Assessment With CCTA and MRI in Asymptomatic Patients With Type 2 Diabetes for Detection of Unrecognized Myocardial Scar in Subclinical Coronary Atherosclerosis
- Acronym
- ACCREDIT
- Condition
- Type 2 Diabetes Mellitus
- Condition
- Coronary Atherosclerosis
- Intervention (Drug)
- iobitridol
- Intervention (Drug)
- gadoterate meglumine
- Lead sponsor
- Guerbet
Record details
- Record id
cardio:ct-nct01254552- Content hash
ce7a19b90350161c0d21c4df6e93f1c0e67281868b89c0ac7aa60028f92027e2